The Role of Gut Microbiota in Gastrointestinal Cancers: From Pathogenesis to Therapeutic Perspectives 2.0

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".

Deadline for manuscript submissions: 31 March 2024 | Viewed by 335

Special Issue Editor

Department of Gastroenterological Endoscopy, Tokyo Medical University, Tokyo, Japan
Interests: gastric cancer; intestinal metaplasia; gastritis; tumor immunity; helicobacter pylori; gastric microbiota; endoscopy; cancer surveillance; cancer chemoprevention; colorectal cancer; artificial intelligence
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue will focus on the role of gut microbiota in gastrointestinal cancers, from pathogenesis to therapeutic perspectives, and old and new tools used to evaluate carcinogenesis in vitro and in vivo.

We emphasize the relevance of driver microbiota that accelerate inflammation and carcinogenesis, such as Fusobacterium spp. and others. This Issue includes reviews, opinions, and short articles from experts in the field.

Submissions will cover all types of microbiota, including bacteria, fungi, viruses, and bacteriophages that influence carcinogenesis and molecular pathways/factors playing critical roles in persistent inflammation, various mouse models, and valuable cell lines, primary organoids, and comparative studies with other tumor entities.

We also expand on our issue between metabolites derived from these microbiomes and carcinogenesis.

Review manuscript submissions focusing on innovative therapeutic targets and potential clinical trial candidates, including the molecular mechanisms and the interplay among different signaling pathways, are welcome.

We hope this Special Issue will help improve our understanding of the role of gut microbiota in gastrointestinal cancers.

Dr. Ryota Niikura
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gastric cancer
  • colon cancer
  • esophageal cancer
  • microbiota
  • metaplasia
  • mouse model
  • organoid
  • Helicobacter
  • Fusobacterium spp.
  • eradication
  • signaling pathways
  • cell crosstalk
  • genetics
  • immunological milieu

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop